| 
Results for cryopyrinassociated. Search took 0.06 seconds.
Arcalyst: New Orphan Drug FDA-Approved for Treatment of Rare Inflammatory Syndromes
in Straightfromthedoc, on February 28, 2008
The FDA has just approved a new orphan drug for the treatment of rare inflammatory syndromes.
The said dug - Arcalyst - is the first treatment for an extremely rare condition known as Cryopyrin-Associated Periodic Syndrome or CAPS .
Arcalyst ( rilonacept, an Interleukin-1 blocker ) is no...